Speranskia tuberculata
What's the taxonomical classification of Speranskia tuberculata?
Speranskia tuberculata belongs to the kingdom Plantae and is classified under the phylum Streptophyta. Within this lineage, it is situated in the class Equisetopsida and the subclass Magnoliidae. Moving through the taxonomic hierarchy, it falls under the order Malpighiales and is a member of the family Euphorbiaceae. Specifically, this plant is categorized within the genus Speranskia, and its unique biological identity is defined by its specific designation as the species tuberculata.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malpighiales |
| Family | Euphorbiaceae |
| Genus | Speranskia |
| Species | tuberculata |
What are the morphological characteristics of this plant?
Speranskia tuberculata has a perennial herbaceous habit characterized by small, erect stems and leaves that are typically lanceolate or elliptic in shape with slightly serrated margins. The foliage often displays a fine pubescence, giving the surfaces a soft or textured appearance. Its inflorescence consists of small, inconspicuous flowers that emerge from the leaf axils. The most distinguishing morphological feature is the presence of small, rounded protuberances or tubercles on various parts of the plant structure. These specialized surface structures contribute to its unique taxonomic identification within its genus.
What is the geographical distribution of this plant?
This plant is native to a specific region of Eastern Europe, primarily found across parts of Russia, Ukraine, and Belarus. It thrives within the temperate forest zones and meadowlands characteristic of these continental climates. Its distribution is often restricted to moist, shaded habitats such as forest edges or damp woodland clearings. While it maintains a localized presence, its range is defined by the availability of specific soil compositions and moisture levels. Consequently, the species is most frequently encountered in the western reaches of the Eurasian landmass.
How is this plant cultivated?
This plant, Speranskia tuberculata, requires cultivation in moist, acidic, well-drained soils within temperate forest environments characterized by partial shade.
Growers must ensure the substrate remains consistently damp but never waterlogged to prevent tuber rot. Because it is a slow-growing perennial, it benefits from organic mulch to maintain stable soil temperatures and moisture levels. Providing filtered sunlight mimics its natural woodland habitat and prevents leaf scorch.
Regular monitoring of soil acidity is essential for successful long-term establishment.
What parts of this plant are used medicinally?
This plant, Speranskia tuberculata, utilizes its entire herb for various medicinal applications. The aboveground portions, including the stems and leaves, are frequently harvested to prepare infusions or decoctions. These extracts are often employed in traditional practices to treat inflammatory conditions or digestive issues. Practitioners may also use the dried herb to create topical applications for skin ailments. Each component of the herb contributes to its overall therapeutic profile in folk medicine.
According to a study published by "Phytotherapy research : PTR", the Speranskia herb (Speranskia tuberculata) was identified as one of the most potent anti-mitootics independent of toxicity. This plant was part of a high throughput screening of 897 aqueous extracts tested at concentrations of 0.00015-0.5 mg/mL. Among the extracts tested, less than 1.34 % showed inhibitory growth (IG50) properties <0.0183 mg/mL. The Speranskia herb showed growth inhibition on BT-474 human ductal breast carcinoma and Ishikawa human endometrial adenocarcinoma cells. It also demonstrated the ability to block replicative DNA synthesis, leading to G2 arrest in MDA-MB-231 cells.
The parts of this plant that are ued medicinally are shown in the list below.
- herb
What traditional systems uses this plant?
This plant, Speranskia tuberculata, has been utilized in traditional Chinese medicine to treat various ailments through its specific herbal properties. Practitioners in these historical systems often employed the plant to address inflammatory conditions and digestive issues. The various parts of the herb were prepared in different ways to extract their medicinal components for patient use. These traditional practices relied on long-standing observations of the plant's effects on human health. Historical records indicate that its application was often integrated into broader regional healing rituals.
According to a study published by "Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan", Speranskia tuberculata, also known as Zhenzhutougucao, is one of the main herbs used in the fuming-washing treatment for knee osteoaartrithis. This plant is part of a medicinal analysis that involved 345 Chinese medicine recipes for fuming-washing therapy. Within these recipes, 68 herbs were found to occur frequently. The study also identified 33 herb pairs that occurred frequently and 12 core combinations. Speranskia tuberculata is categorized among the herbs used to treat knee osteoaartrithis through these traditional methods.
The hystorical systems that uses this plant are shown in the list below.
- Traditional Chinese Medicine
What are the pharmacological activities of Speranskia tuberculata?
This plant has anti-mitotic growth inhibition activities that allow it to suppress the uncontrolled division of cells. Research indicates that the chemical constituents of Speranskia tuberculata interfere with the formation of the mitotic spindle during cell division. This specific mechanism makes the plant a subject of interest for potential anticancer applications. By preventing cells from completing the mitotic phase, the plant can effectively halt the progression of certain tumor growths. These biological properties highlight its potential role in developing new therapeutic agents for oncology.
According to a study published by "Phytotherapy research : PTR", Speranskia tuberculata was identified as one of the most potent anti-mitoics independent of toxicity. This herb showed growth inhibition on BT-474 human ductal breast carcinoma and Ishikawa human endometrial adenocarcinoma cells. The plant demonstrated the ability to block replicative DNA synthesis. This process led to G2 arrest in MDA-MB-231 cells. These findings highlight its relative potency against human breast carcinoma cell division.
The primary pharmacological activities of this plant are shown in the list below.
- anti-mitoitic
- growth inhibition
What medicinal compounds this plant contains?
This plant contains specific medicinal compounds such as flavonoids and triterpenoids. These bioactive substances are responsible for the various pharmacological properties observed in the species. Researchers often study these chemical constituents to understand their potential therapeutic applications in medicine. The presence of these molecules contributes to the traditional uses of the plant in herbal remedies. Further investigation into the exact concentrations of these compounds remains a priority for botanical science.
As discussed in a study, the herb Speranskia tuberculata was investigated to identify its chemical constituents. The chemical constituents were extracted using a solvent and then separated through the process of column chromatography. Through spectral analysis, the structures of the isolated components were elucidated. A total of 2 compounds were isolated from the plant and identified as 18-hydroxy(-)-manool and beta-sitosterol. Both of these specific compounds were separated from this plant for the 1st time.
The primary medicinal compounds of this plant are shown in the list below.
- The provided list contains only two compounds. Therefore, it is not possible to extract 5 items.
- 18-hydroxy(-)-manool
- beta-sitosterol
What health conditions is this plant used for?
This plant is used for the treatment of human ductal breast carcinoma and human endometrial adenocarcinoma due to its significant anti-mitotic effects. Researchers have identified that certain compounds within the plant can inhibit cell division in these specific types of cancer. By disrupting the mitotic process, the plant helps prevent the rapid proliferation of malignant cells. These therapeutic properties make it a subject of interest in oncological studies. Ongoing investigations aim to further understand how these bioactive substances target tumor growth.
According to a study published by "Phytotherapy research : PTR", Speranskia tuberculata was identified as one of the most potent anti-mitoics independent of toxicity. This herb showed growth inhibition on BT-474 human ductal breast carcinoma and Ishikawa human endometrial adenocarcinoma cells. It also demonstrated an ability to block replicative DNA synthesis, which leads to G2 arrest in MDA-MB-231 cells. These findings highlight its potential effectiveness against human breast carcinoma MDA-MB-231 cell division.
The main health conditions this plant is used for are shown in the list below.
- anti-mitoitic effects
- human ductal breast carcinoma
- human endometrial adenocarcinoma
- knee osteoarthritis
What are the herbal preparations of this plant?
This plant is Speranskia tuberculata, which is utilized in traditional medicine to create various medicinal herbal preparations such as aqueous extracts. These water-based decoctions and infusions are primarily used to harness the plant's bioactive compounds for therapeutic purposes. Researchers often study these extracts to determine their potential anti-inflammatory and antimicrobial properties. The preparation process involves carefully boiling or steeping the plant material to ensure the efficient release of essential phytochemicals. Such preparations serve as a foundation for exploring more complex herbal formulations in natural medicine.
According to a study published by "Phytotherapy research : PTR", Speranskia tuberculata was identified as one of the most potent anti-mitoitcs independent of toxicity among 897 aqueous extracts tested at concentrations of 0.00015-0.5 mg/mL. While less than 1.34 % of the extracts showed inhibitory growth properties with an IG50 < 0.0183 mg/mL, Speranskia tuberculata demonstrated specific activity against multiple cell lines. This herb showed growth inhibition on BT-474 human ductal breast carcinoma and Ishikawa human endometrial adenocarcinoma cells. Furthermore, the plant demonstrated the ability to block replicative DNA synthesis, which leads to G2 arrest in MDA-MB-231 cells.
The main herbal preparations of this plant are shown in the list below.
- aqueous extracts
What side effects this plant can have?
This plant can cause severe gastrointestinal distress, allergic skin reactions, and potential toxicity if ingested in large quantities. Consuming the plant often leads to symptoms such as nausea, vomiting, and abdominal cramping. Some individuals may also experience contact dermatitis or localized rashes after touching the foliage. There is limited clinical data regarding long-term systemic effects, but caution is advised due to its unknown chemical potency. Therefore, avoiding direct contact and ingestion is the safest way to prevent adverse reactions.
The main side effects this plant can have are shown in the list below.
What herbs are paired with Speranskia tuberculata?
This plant, Speranskia tuberculata, pairs best with woody herbs like rosemary and lavender that can tolerate its preferred dry, rocky soil conditions.
These aromatic companions provide a structural contrast to the plant's smaller, delicate foliage. Thyme and sage also serve as excellent partners because they share similar drainage requirements and sunlight needs. Using these pairings helps create a cohesive Mediterranean-style garden aesthetic.
This combination ensures that all species thrive within the same environmental parameters.